Similar articles for PMID: 27084892

Year	Number of Results
1868	1
1946	1
1949	1
1950	1
1951	1
1952	1
1953	2
1956	2
1958	1
1961	2
1963	2
1964	2
1965	2
1991	1
1993	1
1994	2
1995	1
1996	3
1997	1
1998	3
1999	2
2000	3
2001	3
2002	4
2003	1
2004	2
2005	2
2006	8
2007	7
2008	2
2009	5
2010	2
2011	3
2012	5
2013	4
2014	8
2015	4
2016	14
2017	8
2018	2
2019	6
2020	6
2021	2
2022	5
2023	3
2024	0

1

Prevalence of Non-Cytochrome P450-Mediated Metabolism in Food and Drug Administration-Approved Oral and Intravenous Drugs: 2006-2015.

Cerny MA. Cerny MA. Drug Metab Dispos. 2016 Aug;44(8):1246-52. doi: 10.1124/dmd.116.070763. Epub 2016 Apr 15. Drug Metab Dispos. 2016. PMID: 27084892 Review.

2

Cytochrome P450 and Non-Cytochrome P450 Oxidative Metabolism: Contributions to the Pharmacokinetics, Safety, and Efficacy of Xenobiotics.

Foti RS, Dalvie DK. Foti RS, et al. Drug Metab Dispos. 2016 Aug;44(8):1229-45. doi: 10.1124/dmd.116.071753. Epub 2016 Jun 13. Drug Metab Dispos. 2016. PMID: 27298339

3

Physicochemical Properties, Biotransformation, and Transport Pathways of Established and Newly Approved Medications: A Systematic Review of the Top 200 Most Prescribed Drugs vs. the FDA-Approved Drugs Between 2005 and 2016.

Saravanakumar A, Sadighi A, Ryu R, Akhlaghi F. Saravanakumar A, et al. Clin Pharmacokinet. 2019 Oct;58(10):1281-1294. doi: 10.1007/s40262-019-00750-8. Clin Pharmacokinet. 2019. PMID: 30972694 Free PMC article.

4

Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes.

Uno Y, Uehara S, Yamazaki H. Uno Y, et al. Biochem Pharmacol. 2016 Dec 1;121:1-7. doi: 10.1016/j.bcp.2016.06.008. Epub 2016 Jun 16. Biochem Pharmacol. 2016. PMID: 27318253 Review.

5

Cytochrome P450-mediated metabolism in the human gut wall.

Thelen K, Dressman JB. Thelen K, et al. J Pharm Pharmacol. 2009 May;61(5):541-58. doi: 10.1211/jpp/61.05.0002. J Pharm Pharmacol. 2009. PMID: 19405992 Review.

6

Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.

Crouch RD, Morrison RD, Byers FW, Lindsley CW, Emmitte KA, Daniels JS. Crouch RD, et al. Drug Metab Dispos. 2016 Aug;44(8):1296-303. doi: 10.1124/dmd.115.068338. Epub 2016 Mar 2. Drug Metab Dispos. 2016. PMID: 26936972 Free PMC article.

7

High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury.

Yu K, Geng X, Chen M, Zhang J, Wang B, Ilic K, Tong W. Yu K, et al. Drug Metab Dispos. 2014 Apr;42(4):744-50. doi: 10.1124/dmd.113.056267. Epub 2014 Jan 24. Drug Metab Dispos. 2014. PMID: 24464804

8

Drug Metabolism in the Liver.

Almazroo OA, Miah MK, Venkataramanan R. Almazroo OA, et al. Clin Liver Dis. 2017 Feb;21(1):1-20. doi: 10.1016/j.cld.2016.08.001. Epub 2016 Oct 15. Clin Liver Dis. 2017. PMID: 27842765 Review.

9

Contribution of metabolites to P450 inhibition-based drug-drug interactions: scholarship from the drug metabolism leadership group of the innovation and quality consortium metabolite group.

Yu H, Balani SK, Chen W, Cui D, He L, Humphreys WG, Mao J, Lai WG, Lee AJ, Lim HK, MacLauchlin C, Prakash C, Surapaneni S, Tse S, Upthagrove A, Walsky RL, Wen B, Zeng Z. Yu H, et al. Drug Metab Dispos. 2015 Apr;43(4):620-30. doi: 10.1124/dmd.114.059345. Epub 2015 Feb 5. Drug Metab Dispos. 2015. PMID: 25655830

10

[Cytochrome P450 enzymes and their role in drug interactions].

Papp-Jámbor C, Jaschinski U, Forst H. Papp-Jámbor C, et al. Anaesthesist. 2002 Jan;51(1):2-15. doi: 10.1007/s101-002-8365-5. Anaesthesist. 2002. PMID: 11963295 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

126 results

Results by year